Organon] Confidential To: Subject: SEPARATION AGREEMENT AND GENERAL RELEASE Date:Separation Agreement • February 26th, 2024 • Organon & Co. • Pharmaceutical preparations
This memorandum will confirm that your employment at Organon & Co. (“Organon” or the "Company") and/or one of its Affiliates (as defined below) is ending as the result of a termination without cause. You are entitled to certain benefits in accordance with the Organon Executive Severance Program ("Severance Program") provided that you sign and do not revoke the attached Separation Agreement and General Release ("Separation Agreement") in accordance with the time periods set forth below.
